Research.Patient.info
Urinary Bladder Neoplasms research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE3
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
This study, called NIAGARA-2, is looking at a new way to treat bladder cancer that has grown into the muscle. It combines a drug called durvalumab with standard chemotherapy, given before and after surgery. The aim is to see if this combination improves treatment.
Australia · Brazil · Canada - recruitingPHASE3
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
This study compares two common medicines, azathioprine and methotrexate, when used with adalimumab for Crohn's disease. Researchers want to see which combination works best to improve symptoms and healing in the gut, hoping to find a safer and more effective treatment.
France